Clinical trial

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil…

NCT00152230 · Taiho Pharmaceutical Co., Ltd., Industry · Completed

Key facts

NCT number NCT00152230
Title A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)
Official title A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of UFT Compared With Surgery Alone in Patients With Dukes C Colorectal Cancer (NSAS-CC)
Lead sponsor Taiho Pharmaceutical Co., Ltd., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Colorectal Cancer
Intervention type Drug, Procedure
Interventions UFT (uracil, tegafur), Surgery alone
Enrollment 900
Start date Oct 1, 1996
Primary completion Mar 1, 2006
Completion Feb 1, 2008
First posted Sep 9, 2005
Last update posted Jul 7, 2011
Countries Japan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies